ALLO
ALLOGENE THERAP (ALLO)
NASDAQ
$0.90-$0.03 (-3.10%)
Price as of Nov 11, 2026 7:47 PM EST
  • $322.9M
    Market Cap
  • -24.85%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 46
Valuation
ALLO
vs History
vs S&P 500
Profitability
-1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 33
Valuation
ALLO
vs History
vs S&P 500
3-Month Momentum
-33.33%
12-Month Momentum
18.64%
3-Month Risk Adjusted Momentum
-155.70%
12-Month Risk Adjusted Momentum
23.33%

True Yield

N/A
Valuation
ALLO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.0007%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
ALLO
vs History
vs S&P 500
Ohlson's O-Score
5